Symbol="DBVT"
AssetType="Common Stock"
Name="DBV Technologies"
Description="DBV Technologies SA, a clinical-stage biopharmaceutical company, is dedicated to the research and development of epicutaneous immunotherapy products. The company is headquartered in Montrouge, France."
CIK="1613780"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="177-181 AVENUE PIERRE BROSSOLETTE, MONTROUGE, FR"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="355562000"
EBITDA="-86667504"
PERatio="None"
PEGRatio="0"
BookValue="0.953"
DividendPerShare="0"
DividendYield="0"
EPS="-0.55"
RevenuePerShareTTM="0.026"
ProfitMargin="0"
OperatingMarginTTM="-22.49"
ReturnOnAssetsTTM="-0.36"
ReturnOnEquityTTM="-0.767"
RevenueTTM="4492000"
GrossProfitTTM="4844000"
DilutedEPSTTM="-0.55"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.138"
AnalystTargetPrice="5.13"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="28.15"
PriceToBookRatio="1.356"
EVToRevenue="-"
EVToEBITDA="-0.989"
Beta="1.184"
num_52WeekHigh="2.78"
num_52WeekLow="1.08"
num_50DayMovingAverage="1.844"
num_200DayMovingAverage="1.614"
SharesOutstanding="188095000"
DividendDate="None"
ExDividendDate="None"
symbol="DBVT"
open="1.80"
high="1.80"
low="1.75"
price="1.77"
volume="32574.00"
latest_trading_day="2023-07-06"
previous_close="1.83"
change="-0.06"
change_percent="-3.2787%"
aroon_positive_momentum_days="100"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="100"
Volume_recent_avg="116290"
Change_recent_avg="-0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.7"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="100"
Aroon_momentum_negative="0"
image_negative_thumbnail_id_1="1108"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0141.jpeg"
image_negative_thumbnail_id_2="120"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0056.jpeg"
image_neutral_thumbnail_id_1="580"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0019.jpeg"
image_neutral_thumbnail_id_2="597"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0002.jpeg"
image_positive_thumbnail_id_1="1009"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0171.jpeg"
image_positive_thumbnail_id_2="610"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0098.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
